Pages that link to "Q39882468"
Jump to navigation
Jump to search
The following pages link to The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice (Q39882468):
Displaying 47 items.
- Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter (Q26801110) (← links)
- Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke (Q26864317) (← links)
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance (Q26865927) (← links)
- Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury (Q28088708) (← links)
- Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro (Q28537944) (← links)
- Assessment of drug transporter function using fluorescent cell imaging (Q30571452) (← links)
- Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein (Q34035224) (← links)
- Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport (Q34166212) (← links)
- ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS (Q35056738) (← links)
- ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors (Q35171274) (← links)
- Choroid plexus transport: gene deletion studies (Q35596169) (← links)
- Interaction of innovative small molecule drugs used for cancer therapy with drug transporters (Q35708124) (← links)
- Brain metastases from renal cell carcinoma in the era of tyrosine kinase inhibitors (Q35743315) (← links)
- Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery (Q35855634) (← links)
- Visualizing spatial distribution of alectinib in murine brain using quantitative mass spectrometry imaging (Q35973401) (← links)
- In vivo evaluation of limiting brain penetration of probes for α(2C)-adrenoceptor using small-animal positron emission tomography (Q36012375) (← links)
- Endocrine and metabolic regulation of renal drug transporters (Q36335726) (← links)
- Improving the prediction of the brain disposition for orally administered drugs using BDDCS. (Q36394062) (← links)
- Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approach (Q37207750) (← links)
- Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications (Q37353400) (← links)
- P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain (Q37504578) (← links)
- Pharmacogenetics of membrane transporters: an update on current approaches (Q37641869) (← links)
- Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy (Q37735146) (← links)
- Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance? (Q37853578) (← links)
- Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration (Q37942267) (← links)
- Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications (Q38071700) (← links)
- Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics (Q38207943) (← links)
- In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery (Q38214334) (← links)
- Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux. (Q38233105) (← links)
- ABCG2/BCRP: Specific and Nonspecific Modulators. (Q39049159) (← links)
- Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics (Q39599954) (← links)
- Synthesis and in vivo evaluation of 18F-fluoroethyl GF120918 and XR9576 as positron emission tomography probes for assessing the function of drug efflux transporters (Q39615712) (← links)
- Insights From an Integrated Physiologically Based Pharmacokinetic Model for Brain Penetration. (Q40002947) (← links)
- Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro. (Q40926668) (← links)
- Inhibitory effects of neochamaejasmin B on P-glycoprotein in MDCK-hMDR1 cells and molecular docking of NCB binding in P-glycoprotein. (Q41440285) (← links)
- Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats (Q41651512) (← links)
- Breast cancer resistance protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699). (Q44226295) (← links)
- Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation (Q46550033) (← links)
- Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates (Q47100454) (← links)
- P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine (Q47988249) (← links)
- Dual mTORC1 and mTORC2 inhibitor Palomid 529 penetrates the blood-brain barrier without restriction by ABCB1 and ABCG2. (Q48151074) (← links)
- Evaluation of limiting brain penetration related to P-glycoprotein and breast cancer resistance protein using [(11)C]GF120918 by PET in mice (Q48243022) (← links)
- Hydrophilic anti-migraine triptans are substrates for OATP1A2, a transporter expressed at human blood-brain barrier (Q48564258) (← links)
- BCRP at the Blood−Brain Barrier: Genomic Regulation by 17β-Estradiol (Q51545799) (← links)
- Revisiting the role of ABC transporters in multidrug-resistant cancer. (Q52593092) (← links)
- Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models (Q88245140) (← links)
- No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects (Q90863550) (← links)